Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Poliovirus vaccine inactivated - Panacea Biotec

Next Previous
Drug Profile

Poliovirus vaccine inactivated - Panacea Biotec

Alternative Names: Inactivated poliovirus vaccine - Chiron Panacea; Inactivated poliovirus vaccine - Panacea Biotec; Injectable poliovirus vaccine - Panacea Biotec; Polprotec

Latest Information Update: 21 Apr 2016

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Panacea Biotec
  • Class Viral vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Poliomyelitis

Most Recent Events

  • 20 Apr 2016 No recent reports on development identified - Registered for Poliomyelitis in Bangladesh (IM)
  • 01 Jan 2014 Launched for Poliomyelitis (prevention) in Philippines (IM)
  • 01 Jan 2014 Registered for Poliomyelitis in Bangladesh (prevention) (IM)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top